SecBot SecBot

PHG

KONINKLIJKE PHILIPS NV
NYSE· X-Ray Apparatus & Tubes & Related Irradiation Apparatus· Inc. P7· CIK 0000313216 Healthcare & Medical Devices
$30.14 −0.20 (−0.66%)
Nov 16 4:00 PM ET · prev $30.34
Market cap
$29.5B
Large cap
Median target
$32.50
+8% · range $29.70–41.00
1 year
+7.7%
from $27.98 · Nov 17
30 days
+18.2%
from $25.50
52-week range
$23.81–32.91
−8% from high · low Oct 1
Avg volume 20D
1.58M
shares / day
Short interest
2.08M
≈0.2% of shares · −25.6%
Days to cover
1.7
at average volume
New fund stakes
0
Q3 2026 13F · 1 exit
Filing reports
8
analyzed by SecBot
SecBot read MIXED 5 reports · 90 days
Balance 0 bearish · 0 bullish · 5 neutral oldest → newest, height = score
Avg score ·High conf. 5/5

Price

Daily candles with volume. Callouts mark insider and congressional trades, rating changes, 13F stakes, reports, catalysts, court and regulator actions, Reddit spikes and short-interest jumps. Hover one for the details (tap on phones).

Signal stack

Where each data set points today.

  • InstitutionsBULLISH

    Q3 2026: 20 added (0 new), 12 trimmed or exited.

  • Short sellersCOVERING

    Short interest −25.6% to 2.08M shares. 1.7 days to cover, ≈0.2% of shares.

  • TrendUPTREND

    15% above its 50-day average.

  • SocialQUIET

    No Reddit mentions this week. Last mention Nov 10.

Who's buying

13F· Q3 2026
0
new positions
1
exit
FundMoveSharesValue
UBS Group AGTRIM316,637$7.7M
HRT FINANCIAL LPADD302,677$7.4M
Creative PlanningADD130,931$3.2M
Orion Porfolio Solutions, LLCADD66,199$1.6M
Nuveen, LLCTRIM55,279$1.4M
IEQ CAPITAL, LLCTRIM24,092$588.6K
Savant Capital, LLCADD21,454$524.1K
MML INVESTORS SERVICES, LLCTRIM20,918$511.0K

Quarterly 13F filings are due 45 days after each quarter ends.

The Street

Last action Aug 2026
12-month targets · 5 analysts

Price is inside the target range. Median implies +8%.Targets as of Nov 17, 2026.

Recent actions
DateFirmActionRating
Aug 3, 2026UBS
DOWNGRADE
DOWNGRADENeutral

Earnings setup

Estimates

Revision history: 🔒 Fresh data, subscribers only

PeriodEPS est.Range30D rev.Revenue
Current Q🔒 Fresh data, subscribers only
Next Q🔒 Fresh data, subscribers only
Current FY🔒 Fresh data, subscribers only
Next FY🔒 Fresh data, subscribers only
Catalysts
Scheduled dates and disclosed events: earnings, FDA and trial readouts, halts, press releases. Colored dot = impact.
Recent
Nov 16, 2026
Press release
🔒 Fresh data, subscribers only
Nov 3, 2026
Earnings
Philips delivers strong order intake growth, comparable sales growth and strong margin expansion in Q3; 2026 outlook reiterated
November 3, 2026 Q3 2026 Group performance
Oct 30, 2026
Press release
Philips launches HyperVue Integrated System in the U.S., bringing advanced coronary imaging and physiology into the cathlab
Commercial availability of the HyperVue Integrated System
Oct 29, 2026
Earnings
Philips launches UniGuide 3D Live Guidance, bringing CT planning into live procedures and extending the capabilities of its Azurion image-guided therapy platform
October 29, 2026
Oct 15, 2026
Press release
EXIT-CVD research consortium launches clinical studies to transform cardiovascular care across Europe
October 15, 2026 Five-year research project unites 42 public and private partners across 17 countries to conduct 22 clinical studies involving…

SecBot reports

8 filings · 4 press releases · 1 bullish · 0 bearish · 1 mixed · 6 neutral
All PHG filing & press-release reports (12)